Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10211 | 31430628 | Clin Neurol Neurosurg | Spinal epidural lipomatosis is associated with liver fat deposition and dysfunction. | 2019 | Details |
| A10221 | 31423319 | BMJ Open Gastroenterol | High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study. | 2019 | Details |
| A10222 | 31422872 | Trends Endocrinol Metab | Are Lifestyle Therapies Effective for NAFLD Treatment? | 2019 | Details |
| A10252 | 31410156 | Exp Ther Med | Role and effective therapeutic target of gut microbiota in NAFLD/NASH. | 2019 | Details |
| A10268 | 31405697 | Diabetes Metab Syndr | Partitioning of radiological, stress and biochemical changes in pre-diabetic women subjected to Diabetic Yoga Protocol. | 2019 | Details |
| A10401 | 31353974 | Expert Rev Gastroenterol Hepatol | Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations. | 2019 | Details |
| A10411 | 31347138 | Infection | Epidemiological and etiological variations in hepatocellular carcinoma. | 2019 | Details |
| A10415 | 31345163 | BMC Gastroenterol | Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. | 2019 | Details |
| A10423 | 31342533 | Aliment Pharmacol Ther | Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. | 2019 | Details |
| A10437 | 31336526 | Diabetes Metab Syndr | Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. | 2019 | Details |
| A10453 | 31330977 | Antioxidants (Basel) | Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review. | 2019 | Details |
| A10455 | 31330553 | Semin Liver Dis | Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation? | 2019 | Details |
| A10488 | 31315223 | Nutrients | Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver. | 2019 | Details |
| A10492 | 31312990 | Dig Dis Sci | Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. | 2019 | Details |
| A10502 | 31309820 | Curr Vasc Pharmacol | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. | 2019 | Details |
| A10509 | 31308686 | Nutr Metab Insights | Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. | 2019 | Details |
| A10511 | 31308382 | Sci Rep | Natural course of fatty liver in 36,195 South Korean adults. | 2019 | Details |
| A10522 | 31303681 | J Okla State Med Assoc | Overview of Pediatric Nonalcoholic Fatty Liver Disease: A Guide for General Practitioners. | 2018 | Details |
| A10535 | 31298151 | Curr Pharm Des | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. | 2019 | Details |
| A10547 | 31293337 | World J Gastroenterol | Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. | 2019 | Details |
| A10549 | 31293021 | Phytother Res | The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial. | 2019 | Details |
| A10581 | 31281067 | Dig Liver Dis | Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease. | 2019 | Details |
| A10597 | 31275587 | BMJ Open Gastroenterol | Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study. | 2019 | Details |
| A10601 | 31275407 | Evid Based Complement Alternat Med | Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review. | 2019 | Details |
| A10608 | 31273595 | Dig Dis Sci | Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. | 2019 | Details |
| A10616 | 31270280 | Fukushima J Med Sci | Autoimmune hepatitis, fatty liver, and Fukushima. | 2019 | Details |
| A10628 | 31264313 | Phytother Res | Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial. | 2019 | Details |
| A10636 | 31260143 | J Gastroenterol Hepatol | Genetic and lifestyle risk factors for advanced liver disease among men and women. | 2019 | Details |
| A10639 | 31258620 | Therap Adv Gastroenterol | The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. | 2019 | Details |
| A10664 | 31245932 | Obesity (Silver Spring) | Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study. | 2019 | Details |
| A10707 | 31227825 | Hum Mol Genet | Recent advances in novel therapies for lipid disorders. | 2019 | Details |
| A10728 | 31219486 | Saudi Med J | Position statement on the diagnosis and management of non-alcoholic fatty liver disease. | 2019 | Details |
| A10729 | 31219362 | Infect Dis (Lond) | Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10738 | 31215262 | Expert Rev Gastroenterol Hepatol | Olive oil antioxidants and non-alcoholic fatty liver disease. | 2019 | Details |
| A10758 | 31207986 | J Clin Med | Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes. | 2019 | Details |
| A10831 | 31168845 | J Cell Biochem | Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial. | 2019 | Details |
| A10842 | 31162803 | Liver Int | Association between nut consumption and non-alcoholic fatty liver disease in adults. | 2019 | Details |
| A10852 | 31156558 | Front Endocrinol (Lausanne) | Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment. | 2019 | Details |
| A10863 | 31151875 | Ann Hepatol | Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. | 2019 | Details |
| A10869 | 31149341 | Pharmacol Res Perspect | A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH). | 2019 | Details |
| A10893 | 31136997 | Top Antivir Med | Fatty liver disease in persons with HIV infection. | 2019 | Details |
| A10912 | 31128886 | J Pediatr | The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease. | 2019 | Details |
| A10947 | 31108934 | Nutrients | Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003⁻2014. | 2019 | Details |
| A10961 | 31101782 | Georgian Med News | COMPARATIVE ANALYSIS OF EFFICIENCY OF URSODEOXYCHOLIC ACID AND COMBINATION OF VITAMIN E AND VITAMIN C IN TREATMENT OF NON-DIABETIC NONALCOHOLIC STEATOHEPATITIS. | 2019 | Details |
| A10999 | 31085617 | Postgrad Med J | Diagnosis and management of non-alcoholic fatty liver disease. | 2019 | Details |
| A11009 | 31082855 | Clin Transl Gastroenterol | Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11034 | 31075323 | J Hepatol | The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. | 2019 | Details |
| A11046 | 31070259 | Hepatology | Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta-Analysis. | 2019 | Details |
| A11048 | 31069057 | F1000Res | Recent advances in the understanding and management of polycystic ovary syndrome. | 2019 | Details |
| A11066 | 31061050 | BMJ Open | Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort. | 2019 | Details |
| A11070 | 31060228 | Biomolecules | Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague⁻Dawley Rats †. | 2019 | Details |
| A11112 | 31036494 | Ann Hepatol | Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). | 2019 | Details |
| A11113 | 31035998 | BMC Med | Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity. | 2019 | Details |
| A11133 | 31028350 | Nat Rev Gastroenterol Hepatol | From NASH to HCC: current concepts and future challenges. | 2019 | Details |
| A11157 | 31018719 | Expert Rev Gastroenterol Hepatol | Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11212 | 30993937 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment. | 2019 | Details |
| A11218 | 30991446 | Hepatology | Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11242 | 30977830 | J Clin Endocrinol Metab | Diet-Dependent Acid Load-The Missing Link Between an Animal Protein-Rich Diet and Nonalcoholic Fatty Liver Disease? | 2019 | Details |
| A11265 | 30968772 | Curr Med Chem | Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A11266 | 30968561 | J Dig Dis | What are the main areas of focus to prevent or treat non-alcoholic fatty liver disease? | 2019 | Details |
| A11269 | 30965381 | Z Gastroenterol | Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. | 2019 | Details |
| A11279 | 30961499 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. | 2020 | Details |
| A11290 | 30953079 | J Mol Med (Berl) | Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology. | 2019 | Details |
| A11319 | 30940296 | Gene Expr | Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment. | 2019 | Details |
| A11341 | 30930223 | J Hepatol | The circadian clock and liver function in health and disease. | 2019 | Details |
| A11357 | 30924429 | Proc Nutr Soc | From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis. | 2019 | Details |
| A11365 | 30920975 | Eur J Gastroenterol Hepatol | Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial. | 2019 | Details |
| A11373 | 30919338 | Adv Exp Med Biol | Circular RNAs as Potential Biomarkers and Therapeutic Targets for Metabolic Diseases. | 2019 | Details |
| A11376 | 30919112 | Heart Vessels | High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes. | 2019 | Details |
| A11393 | 30915402 | Clin Exp Hepatol | Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children. | 2019 | Details |
| A11397 | 30913263 | PLoS One | Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective. | 2019 | Details |
| A11420 | 30901929 | Nutrients | Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11433 | 30896960 | Rev Esp Enferm Dig | Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models. | 2019 | Details |
| A11437 | 30896648 | Medicine (Baltimore) | A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11443 | 30892882 | J Agric Food Chem | Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11450 | 30889791 | Medicines (Basel) | The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11456 | 30888594 | Adv Ther | Pharmacological Treatment for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11492 | 30872135 | Arab J Gastroenterol | Relationship between lifestyle factors and nutritional status and non-alcoholic fatty liver disease among a group of adult Jordanians. | 2019 | Details |
| A11499 | 30870804 | Nutrition | Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. | 2018 | Details |
| A11515 | 30862999 | World J Gastroenterol | Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis. | 2019 | Details |
| A11553 | 30844893 | Curr Opin Gastroenterol | Current treatment options for nonalcoholic fatty liver disease. | 2019 | Details |
| A11577 | 30832745 | Br J Nutr | Dietary determinants of hepatic fat content and insulin resistance in overweight/obese children: a cross-sectional analysis of the Prevention of Diabetes in Kids (PREDIKID) study. | 2019 | Details |
| A11589 | 30827909 | Endocrinol Diabetes Nutr (Engl Ed) | Document on a comprehensive approach to type 2 diabetes mellitus. | 2019 | Details |
| A11607 | 30821873 | J Gastroenterol Hepatol | Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis. | 2019 | Details |
| A11673 | 30794300 | JAMA Netw Open | Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis. | 2019 | Details |
| A11685 | 30791768 | Expert Rev Gastroenterol Hepatol | The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies. | 2019 | Details |
| A11686 | 30791767 | Expert Rev Gastroenterol Hepatol | Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. | 2019 | Details |
| A11713 | 30781472 | Antioxidants (Basel) | Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview. | 2019 | Details |
| A11723 | 30776292 | J Clin Endocrinol Metab | Comorbidities in primary versus secondary school children with obesity and responsiveness to lifestyle intervention. | 2019 | Details |
| A11741 | 30770030 | Diab Vasc Dis Res | Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. | 2019 | Details |
| A11784 | 30745819 | Int J Biol Sci | Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates. | 2019 | Details |
| A11805 | 30732664 | Proc Nutr Soc | Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. | 2019 | Details |
| A11811 | 30729382 | Curr Obes Rep | Obesity in South Asia: Phenotype, Morbidities, and Mitigation. | 2019 | Details |
| A11818 | 30721572 | Liver Int | Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease. | 2019 | Details |
| A11828 | 30718741 | Sci Rep | Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention. | 2019 | Details |
| A11831 | 30717085 | Nutrients | Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases. | 2019 | Details |
| A11839 | 30711707 | Toxicology | The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A11844 | 30710884 | Nutrition | No association between fruits or vegetables and non-alcoholic fatty liver disease in middle-aged men and women. | 2018 | Details |
| A11859 | 30706422 | Drugs | L-Ornithine L-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11862 | 30705687 | Nutr Metab (Lond) | Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. | 2019 | Details |